Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stacy Lindborg is President and CEO at Imunon. OQRO lists 15 transactions filed with the SEC under this name, the latest on Nov 11, 2026, each linked to the official Form 4.
President and CEO
Disclosures on record
15
Companies involved
1
ImunonIMNN
15 disclosures · Jan 2026 – Nov 2026
Nov 6, 20263,804disclosed Nov 11
DetailsOfficial recordOct 23, 20262,603disclosed Oct 27
DetailsOfficial recordOct 9, 20262,977disclosed Oct 13
DetailsOfficial recordSep 25, 20266,697disclosed Sep 28
DetailsOfficial recordSep 11, 20265,504disclosed Sep 15
DetailsOfficial recordAug 28, 20266,822disclosed Sep 1
DetailsOfficial recordAug 14, 20266,615disclosed Aug 17
DetailsOfficial recordJul 31, 20265,010disclosed Aug 4
DetailsOfficial recordJul 17, 20264,907disclosed Jul 21
DetailsOfficial recordJul 2, 20262,534disclosed Jul 7
DetailsOfficial recordJun 25, 202667Kdisclosed Jun 29
DetailsOfficial recordJun 18, 20261,803disclosed Jun 23
DetailsOfficial recordJun 5, 20261,593disclosed Jun 9
DetailsOfficial recordMay 22, 20261,491disclosed May 27
DetailsOfficial recordJan 2, 202656Kdisclosed Jan 6
DetailsOfficial recordStacy Lindborg bought shares on the open market in 2024, and has not bought since 2024.
Stacy Lindborg reported 1 open-market purchase and 0 sales since 2024; purchases in 2024.
| Year | Bought | Sold |
|---|---|---|
| 2024 | $25K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Stacy Lindborg reported 1 open-market purchase and 0 sales here, 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
As of the latest filing on , Stacy Lindborg reported holding 122,581 shares of Imunon (IMNN), worth about $77K at the last close of $1 (Nov 13, 2026).
Imunon's proxy statement reports total compensation of $1.03M for Stacy Lindborg for fiscal year 2025, after $1.19M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed May 4, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Imunon IMNN | 122,581 | 123K direct | $1 | $77K | Nov 6, 2026 |
Is this Stacy Lindborg’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 6, 2026, Stacy Lindborg reported holding 122,581 shares of Imunon (IMNN). At the last close of $1 on Nov 13, 2026, that is about $77K. This is the stake disclosed in filings, not a net worth.
Imunon's proxy statement reports total compensation of $1.03M for Stacy Lindborg for fiscal year 2025, after $1.19M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Stacy Lindborg bought shares on the open market in 2024, and has not bought since 2024.
In SEC filings since 2024: the latest open-market purchase is from 2024; no open-market sale is on record.
Imunon (IMNN), from 2024 to 2024: 1 purchase and 0 sales.
